Restrictive cardiomyopathy

New England Journal of Medicine

Volumn 336, Issue 4, 1997, Pages 267-276

  Kushwaha, Sudhir S ^a   Fallon, John T ^a   Fuster, Valentin ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; CORTICOSTEROID; CYTOTOXIC AGENT; DIGOXIN; DIURETIC AGENT; INTERFERON; MELPHALAN; PREALBUMIN; PREDNISONE; WARFARIN;

CARCINOID SYNDROME; CONSTRICTIVE PERICARDITIS; DOPPLER ECHOCARDIOGRAPHY; ENDOCARDITIS; FABRY DISEASE; FAMILIAL DISEASE; GAUCHER DISEASE; HEART AMYLOIDOSIS; HEART FAILURE; HEART MUSCLE FIBROSIS; HEART TRANSPLANTATION; HUMAN; HURLER SYNDROME; LUNG CONGESTION; PRIORITY JOURNAL; RESTRICTIVE CARDIOMYOPATHY; REVIEW; SARCOIDOSIS; STORAGE DISEASE; THROMBUS;

AMYLOIDOSIS; CARDIOMYOPATHY, RESTRICTIVE; ENDOMYOCARDIAL FIBROSIS; EOSINOPHILIA; HUMANS;

EID: 0031012618     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199701233360407     Document Type: Review

References (136)

1. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996;93:841-2.
2. Schoenfeld MH, Supple EW, Dec GW Jr, Fallon JT, Palacios IF. Restrictive cardiomyopathy versus constrictive pericarditis: role of endomyocardial biopsy in avoiding unnecessary thoracotomy. Circulation 1987; 75:1012-7.
3. Abelmann WH. Classification and natural history of primary myocardial disease. Prog Cardiovasc Dis 1984;27:73-94.
4. Goodwin JF. Cardiomyopathies and specific heart muscle diseases: definitions, terminology, classifications and new and old approaches. Postgrad Med J 1992;68:Suppl 1:S3-S6.
5. Benotti JR, Grossman W, Cohn PF. Clinical profile of restrictive cardiomyopathy. Circulation 1980;61:1206-12.
6. Aroney C, Bett N, Radford D. Familial restrictive cardiomyopathy. Aust N Z J Med 1988;18:877-8.
7. Fitzpatrick AP, Shapiro LM, Rickards AF, Poole-Wilson PA. Familial restrictive cardiomyopathy with atrioventricular block and skeletal myopathy. Br Heart J 1990;63:114-8.
8. Branea I, Stanciu L, Tomescu M, Berinde L, Mancas S. The value of echocardiography in the early diagnosis of myocardial impairment due to connective tissue diseases. Med Interne 1986;24:197-205.
9. Schurle DR, Evans RW, Cohlmia JB, Lin J. Restrictive cardiomyopathy in scleroderma. J Kans Med Soc 1984;85:49-50.
10. Navarro-Lopez F, Llorian A, Ferrer-Roca O, Betriu A, Sanz G. Restrictive cardiomyopathy in pseudoxanthoma elasticum. Chest 1980;78: 113-5.
11. Bouchard A, Sanz N, Botvinick EH, et al. Noninvasive assessment of cardiomyopathy in normotensive diabetic patients between 20 and 50 years old. Am J Med 1989;87:160-6.
12. Fein FS, Sonnenblick EH. Diabetic cardiomyopathy. Cardiovasc Drugs Ther 1994;8:65-73.
13. Chew C, Ziady GM, Raphael MJ, Oakley CM. The functional defect in amyloid heart disease: the "stiff heart" syndrome. Am J Cardiol 1975; 36:438-44.
14. Cueto-Garcia L, Tajik AJ, Kyle RA, et al. Serial echocardiographic observations in patients with primary systemic amyloidosis: an introduction to the concept of early (asymptomatic) amyloid infiltration of the heart. Mayo Clin Proc 1984;59:589-97.
15. Matsui Y, Iwai K, Tachibana T, et al. Clinicopathological study of fatal myocardial sarcoidosis. Ann N Y Acad Sci 1976;278:455-69.
16. Perry A, Vuitch F. Causes of death in patients with sarcoidosis: a morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med 1995;119:167-72.
17. Smith RL, Hutchins GM, Sack GH Jr, Ridolfi RL. Unusual cardiac, renal and pulmonary involvement in Gaucher's disease: interstitial glucocerebroside accumulation, pulmonary hypertension and fatal bone marrow embolization. Am J Med 1978;65:352-60.
18. Renteria VG, Ferrans VJ, Roberts WC. The heart in the Hurler syndrome: gross, histologic and ultrastructural observations in five necropsy cases. Am J Cardiol 1976;38:487-501.
19. Dervan JP, Ilercil A, Kane PB, Anagnostopoulos C. Fatty infiltration: another restrictive cardiomyopathic pattern. Cathet Cardiovasc Diagn 1991;22:184-9.
20. Furth PA, Futterweit W, Gorlin R. Refractory biventricular heart failure in secondary hemochromatosis. Am J Med Sci 1985;290:209-13.
21. Hillsley RE, Hernandez E, Steenbergen C, Bashore TM, Harrison JK. Inherited restrictive cardiomyopathy in a 74-year-old woman: a case of Fabry's disease. Am Heart J 1995;129:199-202.
22. Olson LJ, Reeder GS, Noller KL, Edwards WD, Howell RR, Michels VV. Cardiac involvement in glycogen storage disease III: morphologic and biochemical characterization with endomyocardial biopsy. Am J Cardiol 1984;53:980-1.
23. Gilbert EF. The effects of metabolic diseases on the cardiovascular system. Am J Cardiovasc Pathol 1987;1:189-213.
24. Chew CY, Ziady GM, Raphael MJ, Nellen M, Oakley CM. Primary restrictive cardiomyopathy: non-tropical endomyocardial fibrosis and hypereosinophilic heart disease. Br Heart J 1977;39:399-413.
25. Fawzy ME, Ziady G, Halim M, Guindy R, Mercer EN, Feteih N. Endomyocardial fibrosis: report of eight cases. J Am Coll Cardiol 1985;5:983-8.
26. Olsen EG, Spry CJ. Relation between eosinophilia and endomyocardial disease. Prog Cardiovasc Dis 1985;27:241-54.
27. Lundin L, Norheim I, Landelius J, Oberg K, Theodorsson-Norheim E. Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities. Circulation 1988;77:264-9.
28. Pellikka PA, Tajik AJ, Khandheria BK, et al. Carcinoid heart disease: clinical and echocardiographic spectrum in 74 patients. Circulation 1993; 87:1188-96.
29. Roberts WC, Glancy DL, DeVita VT Jr. Heart in malignant lymphoma (Hodgkin's disease, lymphosarcoma, reticulum cell sarcoma and mycosis fungoides): a study of 196 autopsy cases. Am J Cardiol 1968;22:85-107.
30. Stark RM, Perloff JH, Glick HJ, Hirshfeld JW Jr, Devereux RB. Clinical recognition and management of cardiac metastatic disease: observations in a unique case of alveolar soft-part sarcoma. Am J Med 1977;63:653-9.
31. Gottdiener JS, Katin MJ, Borer JS, Bacharach SL, Green MV. Late cardiac effects of therapeutic mediastinal irradiation: assessment by echocardiography and radionuclide angiography. N Engl J Med 1983;308:569-72.
32. Mortensen SA, Olsen HS, Baandrup U. Chronic anthracycline cardiotoxicity: haemodynamic and histopathological manifestations suggesting a restrictive endomyocardial disease. Br Heart J 1986;55:274-82.
33. Bu'Lock FA, Mott MG, Oakhill A, Martin RP. Left ventricular diastolic function after anthracycline chemotherapy in childhood: relation with systolic function, symptoms, and pathophysiology. Br Heart J 1995;73: 340-50.
34. Mason JW, Billingham ME, Friedman JP. Methysergide-induced heart disease: a case of multivalvular and myocardial fibrosis. Circulation 1977; 56:889-90.
35. Billingham ME. Pharmacotoxic myocardial disease: an endomyocardial study. Heart Vessels Suppl 1985;1:278-82.
36. Katritsis D, Wilmshurst PT, Wenden JA, Davies MJ, Webb-Peploe MM. Primary restrictive cardiomyopathy: clinical and pathologic characteristics. J Am Coll Cardiol 1991;18:1230-5.
37. Ishiwata S, Nishiyama S, Seki A, Kojima S. Restrictive cardiomyopathy with complete atrioventricular block and distal myopathy with rimmed vacuoles. Jpn Circ J 1993;57:928-33.
38. Feld S, Caspi A. Familial cardiomyopathy with variable hypertrophic and restrictive features and common HLA haplotype. Isr J Med Sci 1992; 28:277-80.
39. Cooke RA, Chambers JB, Curry PV. Noonan's cardiomyopathy: a non-hypertropnic variant. Br Heart J 1994;71:561-5.
40. Lewis AB. Clinical profile and outcome of restrictive cardiomyopathy in children. Am Heart J 1992;123:1589-93.
41. Cetta F, O'Leary PW, Seward JB, Driscoll DJ. Idiopathic restrictive cardiomyopathy in childhood: diagnostic features and clinical course. Mayo Clin Proc 1995;70:634-40.
42. Hirota Y, Shimizu G, Kita Y, et al. Spectrum of restrictive cardiomyopathy: report of the national survey in Japan. Am Heart J 1990;120:188-94.
43. Siegel RJ, Shah PK, Fishbein MC. Idiopathic restrictive cardiomyopathy. Circulation 1984;70:165-9.
44. Buxbaum J. The amyloidoses. Mt Sinai J Med 1996;63:16-23.
45. Smith TJ, Kyle RA, Lie JT. Clinical significance of histopathologic patterns of cardiac amyloidosis. Mayo Clin Proc 1984;59:547-55.
46. Saraiva MJ. Transthyretin mutations in health and disease. Hum Mutat 1995;5:191-6.
47. Kinoshita O, Hongo M, Yamada H, et al. Impaired left ventricular diastolic filling in patients with familial amyloid polyneuropathy: a pulsed Doppler echocardiographic study. Br Heart J 1989;61:198-203.
48. Hongo M, Fujii T, Hirayama J, Kinoshita O, Tanaka M, Okubo S. Radionuclide angiographic assessment of left ventricular diastolic filling in amyloid heart disease: a study of patients with familial amyloid polyneuropathy. J Am Coll Cardiol 1989;13:48-53.
49. Ranløv I, Alves IL, Ranløv PJ, Husby G, Costa PP, Saraiva MJM. A Danish kindred with familial amyloid cardiomyopathy revisited: identification of a mutant transthyretin-methionine111 variant in serum from patients and carriers. Am J Med 1992;93:3-8.
50. Hesse A, Altland K, Linke RP, et al. Cardiac amyloidosis: a review and report of a new transthyretin (prealbumin) variant. Br Heart J 1993;70: 111-5.
51. Fiori MG, Salvi F, Plasmati R, Tessari F, Bianchi R, Tassinari CA. Amyloid deposits inside myocardial fibers in transthyretin-Met30 familial amyloidotic polyneuropathy: a histological and biochemical study. Cardiology 1994;85:145-53.
52. Saraiva MJ, Almeida M do R, Sherman W, et al. A new transthyretin mutation associated with amyloid cardiomyopathy. Am J Hum Genet 1992;50:1027-30.
53. Thr→Lys, associated with autosomal dominant cardiac amyloidosis in an Italian family. Circulation 1995;91:962-7.
54. Gertz MA, Kyle RA, Thibodeau SN. Familial amyloidosis: a study of 52 North American-born patients examined during a 30-year period. Mayo Clin Proc 1992;67:428-40.
55. Gustavsson A, Engstrom U, Westermark P. Mechanisms of transthyretin amyloidogenesis: antigenic mapping of transthyretin purified from plasma and amyloid fibrils and within in situ tissue localizations. Am J Pathol 1994;144:1301-11.
56. Kawamura S, Takahashi M, Ishihara T, Uchino F. Incidence and distribution of isolated atrial amyloid: histologic and immunohistochemical studies of 100 aging hearts. Pathol Int 1995;45:335-42.
57. Looi LM. Isolated atrial amyloidosis: a clinicopathologic study indicating increased prevalence in chronic heart disease. Hum Pathol 1993;24:602-7.
58. Cueto-Garcia L, Reeder GS, Kyle RA, et al. Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. J Am Coll Cardiol 1985;6:737-43.
59. Klein AL, Hatle LK, Taliercio CP, et al. Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis: a Doppler echocardiography study. Circulation 1991;83:808-16.
60. Falk RH, Lee VW; Rubinow A, Hood WB Jr, Cohen AS. Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis. Am J Cardiol 1983;51:826-30.
61. Lekakis J, Nanas J, Moustafellou C, et al. Cardiac amyloidosis detected by indium-111 antimyosin imaging. Am Heart J 1992;124:1630-1.
62. Falk RH, Rubinow A, Cohen AS. Cardiac arrhythmias in systemic amyloidosis: correlation with echocardiographic abnormalities. J Am Coll Cardiol 1984;3:107-13.
63. Wilmshurst PT, Katritsis D. Restrictive cardiomyopathy. Br Heart J 1990;63:323-4.
64. Olson LJ, Gertz MA, Edwards WD, et al. Senile cardiac amyloidosis with myocardial dysfunction: diagnosis by endomyocardial biopsy and immunohistochemistry. N Engl J Med 1987;317:738-42.
65. Arbustini E, Merlini G, Gavazzi A, et al. Cardiac immunocyte-derived (AL) amyloidosis: an endomyocardial biopsy study in 11 patients. Am Heart J 1995;130:528-36.
66. Hoshii Y, Takahashi M, Ishihara T, Uchino F. Immunohistochemical classification of 140 autopsy cases with systemic amyloidosis. Pathol Int 1994;44:352-8.
67. Gallo G, Wisniewski T, Choi-Miura NH, Ghiso J, Frangione B. Potential role of apolipoprotein-E in fibrillogenesis. Am J Pathol 1994;145:526-30.
68. Li XA, Hatanaka K, Ishibashi-Ueda H, Yutani C, Yamamoto A. Characterization of serum amyloid P component from human aortic atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1995;15:252-7.
69. Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HR, Bjornson BH. The idiopathic hypereosinophilic syndrome: clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med 1982;97:78-92.
70. Tai PC, Ackerman SJ, Spry CJ, Dunnette S, Olsen EG, Gleich GJ. Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet 1987;1:643-7.
71. Schaffer SW, Dimayuga ER, Kayes SG. Development and characterization of a model of eosinophil-mediated cardiomyopathy in rats infected with Toxocara canis. Am J Physiol 1992;262:H1428-H1434.
72. Boustany CW Jr, Murphy GW, Hicks GL Jr. Mitral valve replacement in idiopathic hypereosinophilic syndrome. Ann Thorac Surg 1991;51:1007-9.
73. Bolster MB, Silver RM. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia. Curr Opin Rheumatol 1994; 6:642-9.
74. Berger PB, Duffy J, Reeder GS, Karon BL, Edwards WD. Restrictive cardiomyopathy associated with the eosinophilia-myalgia syndrome. Mayo Clin Proc 1994;69:162-5.
75. Gottdiener JS, Maron BJ, Schooley RT, Harley JB, Roberts WC, Fauci AS. Two-dimensional echocardiographic assessment of the idiopathic hypereosinophilic syndrome: anatomic basis of mitral regurgitation and peripheral embolization. Circulation 1983;67:572-8.
76. Roberts WC, Liegler DG, Carbone PP. Endomyocardial disease and eosinophilia: a clinical and pathologic spectrum. Am J Med 1969;46:28-42.
77. Shaper AG, Hutt MS, Coles RM. Necropsy study of endomyocardial fibrosis and rheumatic heart disease in Uganda 1950-1965. Br Heart J 1968;30:391-401.
78. Becker AE. Pathology of cardiomyopathies. Cardiovasc Clin 1988;19: 9-31.
79. Uyama E, Takahashi K, Owada M, et al. Hydrocephalus, corneal opacities, deafness, valvular heart disease, deformed toes and leptomeningeal fibrous thickening in adult siblings: a new syndrome associated with β-glucocerebrosidose deficiency and a mosaic population of storage cells. Acta Neurol Scand 1992;86:407-20.
80. Angomachalelis N, Hourzamanis A, Vamvalis C, Gavrielides A. Doppler echocardiographic evaluation of left ventricular diastolic function in patients with systemic sarcoidosis. Postgrad Med J 1992;68:Suppl 1:S52-S56.
81. Valantine H, McKenna WJ, Nihoyannopoulos P, et al. Sarcoidosis: a pattern of clinical and morphological presentation. Br Heart J 1987;57:256-63.
82. Gibbons WJ, Levy RD, Nava S, et al. Subclinical cardiac dysfunction in sarcoidosis. Chest 1991;100:44-50.
83. McDougall NI, Purvis JA, Wilson CM, Adgey AA. Asystolic arrest as a presentation of sarcoidosis. Int J Cardiol 1994;47:165-7.
84. Kavanagh T, Huang S. Cardiac sarcoidosis: an unforeseen cause of sudden death. Can J Cardiol 1995;11:136-8.
85. Virmani R, Bures JC, Roberts WC. Cardiac sarcoidosis: a major cause of sudden death in young individuals. Chest 1980;77:423-8.
86. Iwai K, Sekiguti M, Hosoda Y, et al. Racial differences in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis 1994;11:26-31.
87. Tawarahara K, Kurata C, Okayama K, Kobayashi A, Yamazaki N. Thallium-201 and gallium 67 single photon emission computed tomographic imaging in cardiac sarcoidosis. Am Heart J 1992;124:1383-4.
88. Okayama K, Kurata C, Tawarahara K, Wakabayashi Y, Chida K, Sato A. Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest 1995;107:330-4.
89. Saeki M, Kitazawa H, Kodama M, et al. Cardiac sarcoidosis: 67Ga imaging and histology. Circulation 1995;91:2497-8.
90. Ratner SJ, Fenoglio JJ Jr, Ursell PC. Utility of endomyocardial biopsy in the diagnosis of cardiac sarcoidosis. Chest 1986;90:528-33.
91. Valantine HA, Tazelaar HD, Macoviak J, et al. Cardiac sarcoidosis: response to steroids and transplantation. J Heart Transplant 1987;6:244-50.
92. Robiolio PA, Rigolin VH, Wilson JS, et al. Carcinoid heart disease: correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography. Circulation 1995;92:790-5.
93. Lundin L, Funa K, Hansson HE, Wilander E, Oberg K. Histochemical and immunohistochemical morphology of carcinoid heart disease. Pathol Res Pract 1991;187:73-7.
94. Waltenberger J, Lundin L, Oberg K, et al. Involvement of transforming growth factor-beta in the formation of fibrotic lesions in carcinoid heart disease. Am J Pathol 1993;142:71-8.
95. Brosius FC III, Waller BF, Roberts WC. Radiation heart disease: analysis of 16 young (aged 15 to 33 years) necropsy patients who received over 3,500 rads to the heart. Am J Med 1981;70:519-30.
96. Gomez GA, Park JJ, Panahon AM, et al. Heart size and function after radiation therapy to the mediastinum in patients with Hodgkin's disease. Cancer Treat Rep 1983;67:1099-103.
97. Schultz-Hector S, Bohm M, Blochel A, et al. Radiation-induced heart disease: morphology, changes in catecholamine synthesis and content, beta-adrenoceptor density, and hemodynamic function in an experimental model. Radiat Res 1992;129:281-9.
98. Schultz-Hector S, Balz K. Radiation-induced loss of endothelial alkaline phosphatase activity and development of myocardial degeneration: an ultrastructural study. Lab Invest 1994;71:252-60.
99. Schoenfeld MH. The differentiation of restrictive cardiomyopathy from constrictive pericarditis. Cardiol Clin 1990;8:663-71.
100. Eriksson P, Boman K, Jacobsson B, Olofsson BO. Cardiac arrhythmias in familial amyloid polyneuropathy during anaesthesia. Acta Anaesthesiol Scand 1986;30:317-20.
101. Nakata T, Shimamoto K, Yonekura S, et al. Cardiac sympathetic denervation in transthyretin-related familial amyloidotic polyneuropathy: detection with iodine-123-MIBG. J Nucl Med 1995;36:1040-2.
102. Winters SL, Cohen M, Greenberg S, et al. Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol 1991;18:937-43.
103. Child JS, Perloff JK. The restrictive cardiomyopathies. Cardiol Clin 1988;6:289-316.
104. Backes RJ, Gersh BJ. Cardiomyopathies in the elderly. Cardiovasc Clin 1992;22:105-25.
105. Vaitkus PT, Kussmaul WG. Constrictive pericarditis versus restrictive cardiomyopathy: a reappraisal and update of diagnostic criteria. Am Heart J 1991;122:1431-41.
106. Fowler NO. Constrictive pericarditis: its history and current status. Clin Cardiol 1995;18:341-50.
107. Eriksson A, Eriksson P, Olofsson BO, Thornell LE. The cardiac atrioventricular conduction system in familial amyloidosis with polyneuropathy: a clinico-pathologic study of six cases from northern Sweden. Acta Pathol Microbiol Immunol Scand [A] 1983;91:343-9.
108. Appleton CP, Hatle LK, Popp RL. Demonstration of restrictive ventricular physiology by Doppler echocardiography. J Am Coll Cardiol 1988; 11:757-68.
109. Mason JW, O'Connell JB. Clinical merit of endomyocardial biopsy. Circulation 1989;79:971-9.
110. Blake S, Bonar S, O'Neill H, et al. Aetiology of chronic constrictive pericarditis. Br Heart J 1983;50:273-6.
111. Killian DM, Furiasse JG, Scanlon PJ, Loeb HS, Sullivan HJ. Constrictive pericarditis after cardiac surgery. Am Heart J 1989;118:563-8.
112. Cameron J, Oesterle SN, Baldwin JC, Hancock EW. The etiologic spectrum of constrictive pericarditis. Am Heart J 1987;113:354-60.
113. Garrett J, O'Neill H, Blake S. Constrictive pericarditis associated with sarcoidosis. Am Heart J 1984;107:394.
114. Daubert JP, Gaede J, Cohen HJ. A fatal case of constrictive pericarditis due to a marked, selective pericardial accumulation of amyloid. Am J Med 1993;94:335-40.
115. Tyberg TI, Goodyer AV, Hurst VW III, Alexander J, Langou RA. Left ventricular filling in differentiating restrictive amyloid cardiomyopathy and constrictive pericarditis. Am J Cardiol 1981;47:791-6.
116. Aroney CN, Ruddy TD, Dighero H, Fifer MA, Boucher CA, Palacios IF. Differentiation of restrictive cardiomyopathy from pericardial constriction: assessment of diastolic function by radionuclide angiography. J Am Coll Cardiol 1989;13:1007-14.
117. Morgan JM, Raposo L, Clague JC, Chow WH, Oldershaw PJ. Restrictive cardiomyopathy and constrictive pericarditis: non-invasive distinction by digitised M mode echocardiography. Br Heart J 1989;61:29-37.
118. Hatle LK, Appleton CP, Popp RL. Differentiation of constrictive pericarditis and restrictive cardiomyopathy by Doppler echocardiography. Circulation 1989;79:357-70.
119. Klein AL, Cohen GI, Pietrolungo JF, et al. Differentiation of constrictive pericarditis from restrictive cardiomyopathy by Doppler transesophageal echocardiographic measurements of respiratory variations in pulmonary venous flow. J Am Coll Cardiol 1993;22:1935-43.
120. Masui T, Finck S, Higgins CB. Constrictive pericarditis and restrictive cardiomyopathy: evaluation with MR imaging. Radiology 1992;182:369-73.
121. Gertz MA, Kyle RA. Amyloidosis: prognosis and treatment. Semin Arthritis Rheum 1994;24:124-38.
122. Idem. Phase II trial of recombinant Interferon alfa-2 in the treatment of primary systemic amyloidosis. Am J Hematol 1993;44:125-8.
123. Gertz MA, Kyle RA, Greipp PR. Response rates and survival in primary systemic amyloidosis. Blood 1991;77:257-62.
124. Shibuya T, Murakawa M, Tsuda Y, Harada M. Successful treatment of primary amyloidosis with dimethylsulfoxide and cytoreductive chemotherapy. Intern Med 1992;31:544-8.
125. Skinner M, Anderson JJ, Simms R, et al. Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Am J Med 1996;100:290-8.
126. Deng M, Park JW, Roy-Chowdury R, Knieriem HJ, Reinhard U, Heinrich KW. Heart transplantation for restrictive cardiomyopathy: development of cardiac amyloidosis in preexisting monoclonal gammopathy. J Heart Lung Transplant 1992;11:139-41.
127. Dubrey S, Simms RW, Skinner M, Falk RH. Recurrence of primary (AL) amyloidosis in a transplanted heart with four-year survival. Am J Cardiol 1995;76:739-41.
128. Hosenpud JD, DeMarco T, Frazier OH, et al. Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation: follow-up results of a multicenter survey. Circulation 1991;84:Suppl III:III-338-III-343.
129. Kim CH, Vlietstra RE, Edwards WD, Reeder GS, Gleich GJ. Steroid-responsive eosinophilic myocarditis: diagnosis by endomyocardial biopsy. Am J Cardiol 1984;53:1472-3.
130. Metras D, Coulibaly AO, Ouattara K. The surgical treatment of endomyocardial fibrosis: results in 55 patients. Circulation 1985;72:Suppl II: II274-II279.
131. Balakrishnan KG, Venkitachalam CG, Pillai VR, Subramanian R, Valiathan MS. Postoperative evaluation of endomyocardial fibrosis. Cardiology 1986;73:73-84.
132. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996;110:1107-19.
133. Niederau C, Stremmel W, Strohmeyer GW. Clinical spectrum and management of haemochromatosis. Baillieres Clin Haematol 1994;7:881-901.
134. Politi A, Sticca M, Galli M. Reversal of haemochromatotic cardiomyopathy in beta thalassaemia by chelation therapy. Br Heart J 1995;73:486-7.
135. Case Records of the Massachusetts General Hospital (Case 31-1994). N Engl J Med 1994;331:460-6.
136. Oni AA, Hershberger RE, Norman DJ, et al. Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids. J Heart Lung Transplant 1992;11:367-9.